ALGS vs GILD: Which Stock is Better?

Side-by-side comparison of Aligos Therapeutics Inc and Gilead Sciences Inc in 2026

Comparison Updated:

ALGS

Aligos Therapeutics Inc

$6.00

GILD

Gilead Sciences Inc

$130.84

Key Metrics Comparison

MetricALGSGILDWinner
Market Cap$36.94M$159.92BGILD
P/E RatioN/A19.00GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth-0.7%0.0%GILD
Gross Margin-3077.2%78.8%GILD

Analyze ALGS

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ALGS or GILD a better investment?

Comparing ALGS and GILD: Aligos Therapeutics Inc has a market cap of $36.94M while Gilead Sciences Inc has $159.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ALGS and GILD?

ALGS (Aligos Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ALGS or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ALGS or GILD?

GILD has higher revenue growth at 0.0% vs -0.7% for ALGS.

Which company is more profitable: ALGS or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -3077.2% for ALGS.

Which is the larger company: ALGS or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $159.92B compared to $36.94M for ALGS.

Should I buy ALGS or GILD in 2026?

Both ALGS and GILD have investment merit. ALGS trades at $6.00 while GILD trades at $130.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ALGS and GILD stock?

Key differences: Market Cap ($36.94M vs $159.92B), P/E Ratio (N/A vs 19.0x), Revenue Growth (-0.7% vs 0.0%), Gross Margin (-3077.2% vs 78.8%).

Popular Stock Comparisons